# 2026-22954: DEA Revokes Utah Nurse Practitioner’s Controlled-Substance Registration

2026-22954, Traci B. Lujan, A.P.R.N.; Decision and Order, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2026-11-12, effective 2026-12-14; PRIA reads it as touching household money (as of 2026-11-12).

- Canonical: https://policyrisk.com/federal-register/2026-22954
- As of: 2026-11-12
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-22954
- Title: Traci B. Lujan, A.P.R.N.; Decision and Order
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 91 FR 72912
- Published: 2026-11-12
- Effective: 2026-12-14
- Comments close: not stated
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-11-12

## In one line

DEA Revokes Utah Nurse Practitioner’s Controlled-Substance Registration

## Summary

Traci B. Lujan, a nurse practitioner from Utah, lost her DEA registration because she no longer has permission to handle controlled substances in her state. She didn’t ask for a hearing, so the DEA moved forward and officially revoked her certificate. This means she can’t legally prescribe or manage certain medications anymore, effective immediately.

## Effects PRIA read

- DEA Registration Revoked for APRN: cost, high. The DEA revoked Certificate of Registration No. ML5284815 issued to Traci B. Lujan, A.P.R.N. because Utah revoked her RN, APRN, and APRN controlled substance licenses effective April 21, 2026. The DEA order revoking her registration is effective December 14, 2026, and she is therefore not authorize…
- Pending DEA Applications Denied: cost, medium. The DEA denied any pending applications by Traci B. Lujan to renew or modify Certificate No. ML5284815 and denied any other pending application for additional registration in Utah. That denial is part of the same Order effective December 14, 2026.

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22955](https://policyrisk.com/federal-register/2026-22955): Troy R. Lehman, D.O.; Decision and Order, 2026-11-12
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10

## Sources
- [2026-22954 on federalregister.gov](https://www.federalregister.gov/documents/2026/11/12/2026-22954/traci-b-lujan-aprn-decision-and-order)
- [2026-22954 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-11-12/pdf/2026-22954.pdf)

## Related
- [Previous: 2026-22950, Wood Mouldings and Millwork Products From the People's Republic of China: Final…](https://policyrisk.com/federal-register/2026-22950)
- [Next: 2026-22955, Troy R. Lehman, D.O.; Decision and Order](https://policyrisk.com/federal-register/2026-22955)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-22954 (as of 2026-11-12).